Bayban’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.47M Buy
9,346
+1,325
+17% +$350K 1.85% 11
2026
Q2
$2.04M Hold
8,021
– – 1.56% 11
2026
Q1
$1.96M Buy
8,021
+223
+3% +$51.9K 1.7% 10
2025
Q4
$1.61M Buy
+7,798
New +$1.54M 1.43% 10

Other funds holding JNJ

Bayban's JNJ Position: Q3 2026 in Review

Bayban increased its Johnson & Johnson (JNJ) stake by 17% in Q3 2026, buying an estimated $350K and bringing the position to 9,346 shares worth $2.47M. The position accounts for 1.85% of the portfolio, ranked #11.

Bayban first reported a position in JNJ in Q4 2025 and has held it in 4 quarters since. 4,725 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Bayban held 9,346 shares of Johnson & Johnson worth $2.47M as of Q3 2026.
  • Bayban bought 1,325 Johnson & Johnson shares in Q3 2026, an estimated $350K.
  • Johnson & Johnson made up 1.85% of Bayban's portfolio in Q3 2026, its #11 holding.
  • Bayban first reported a position in Johnson & Johnson in Q4 2025 and has held it in 4 quarters since.
  • 4,725 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.